← Back to guidelines
Cardiology13 papers

Bartter syndrome

Last edited: 4/15/2026

Overview

Bartter syndrome is an inherited renal tubular disorder characterized by hypokalemia, hypochloremia, metabolic alkalosis, hyperreninemia, and hyperaldosteronism, with preserved renal function and normotension 13.

Diagnosis

  • Key Symptoms: Hypokalemia, hypochloremia, metabolic alkalosis, muscle weakness, tetany, and growth retardation 13.
  • Laboratory Findings: Hypokalemia (100%), metabolic alkalosis (97.2%), hypocalcemia (92.5%), hypomagnesemia (100%), hyperreninemia, and hyperaldosteronism 1.
  • Genetic Testing: Recommended for accurate diagnosis and guiding specific therapies; common variants include CLCNKB deletions and mutations 2.
  • Management

  • First-Line Treatments: Potassium supplementation to correct hypokalemia 3.
  • Adjunctive Therapies: Thiazide diuretics to increase calcium reabsorption and reduce magnesium wasting 1.
  • Magnesium Supplementation: Considered in cases with hypomagnesemia 1.
  • Calcium Supplementation: May be necessary to manage hypocalcemia 1.
  • Special Populations

  • Pediatrics: Neonatal presentation requires early potassium supplementation for symptom improvement 3.
  • Comorbidities: Patients with CLCNKB mutations, especially homozygous deletions, may develop progressive chronic kidney disease 2.
  • Key Recommendations

  • Genetic Testing for Diagnosis: Perform genetic testing to identify specific mutations guiding targeted therapy (Evidence: Moderate 2).
  • Potassium Supplementation: Initiate potassium supplementation for symptomatic hypokalemia (Evidence: Expert opinion 3).
  • Monitor and Manage Electrolytes: Regularly monitor and manage hypomagnesemia and hypocalcemia with appropriate supplementation (Evidence: Moderate 1).
  • References

    1 Priyadarshi M, Paul SS, Sikdar S, Wig N, Soneja M. Antibiotic-induced Bartter-like syndrome: a systematic review. The Journal of antimicrobial chemotherapy 2025. link 2 Vaisbich MH, Messa ACHL, Rangel-Santos AC, Ferreira JCOA, Nunes FAMDF, Watanabe A. Bartter Syndrome-Related Variants Distribution: Brazilian Data and Its Comparison with Worldwide Cohorts. Nephron 2023. link 3 Kumar PS, Deenadayalan M, Janakiraman L, Vijayakumar M. Neonatal Bartter syndrome. Indian pediatrics 2006. link

    Original source

    1. [1]
      Antibiotic-induced Bartter-like syndrome: a systematic review.Priyadarshi M, Paul SS, Sikdar S, Wig N, Soneja M The Journal of antimicrobial chemotherapy (2025)
    2. [2]
      Bartter Syndrome-Related Variants Distribution: Brazilian Data and Its Comparison with Worldwide Cohorts.Vaisbich MH, Messa ACHL, Rangel-Santos AC, Ferreira JCOA, Nunes FAMDF, Watanabe A Nephron (2023)
    3. [3]
      Neonatal Bartter syndrome.Kumar PS, Deenadayalan M, Janakiraman L, Vijayakumar M Indian pediatrics (2006)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG